Preparation and characterization of two LysB29 specifically labelled fluorescent derivatives of human insulin
暂无分享,去创建一个
[1] J. Whittaker,et al. Structural biology of insulin and IGF1 receptors: implications for drug design , 2002, Nature Reviews Drug Discovery.
[2] M. Weiss,et al. Protein structure and the spandrels of San Marco: insulin's receptor-binding surface is buttressed by an invariant leucine essential for its stability. , 2002, Biochemistry.
[3] A. Beck‐Sickinger,et al. Biophysical methods to study ligand-receptor interactions of neuropeptide Y. , 2001, Biopolymers.
[4] S. Havelund,et al. Ligand-induced conformational change in the minimized insulin receptor. , 2000, Journal of molecular biology.
[5] C. Yip,et al. Mechanism of Transmembrane Signaling: Insulin Binding and the Insulin Receptor† , 2000 .
[6] H. Mazarguil,et al. Design of a fluorescent amino acid derivative usable in peptide synthesis , 2000 .
[7] U. Hassiepen,et al. Analysis of protein self-association at constant concentration by fluorescence-energy transfer. , 1998, European journal of biochemistry.
[8] N. Mckern,et al. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor , 1998, Nature.
[9] N. Kaarsholm,et al. A structural switch in a mutant insulin exposes key residues for receptor binding. , 1998, Journal of Molecular Biology.
[10] P. Basset,et al. Membrane Type-1 Matrix Metalloprotease and Stromelysin-3 Cleave More Efficiently Synthetic Substrates Containing Unusual Amino Acids in Their P1′ Positions* , 1998, The Journal of Biological Chemistry.
[11] G. Sittampalam,et al. Synthesis and characterization of insulin-fluorescein derivatives for bioanalytical applications. , 1997, Analytical chemistry.
[12] E. Amler,et al. Quenching of 7‐chloro‐4‐nitrobenzo‐2‐oxa‐1,3‐diazole‐modified Na+/K+‐ATPase reveals a higher accessibility of the low‐affinity ATP‐binding site , 1997, FEBS letters.
[13] G. Turcatti,et al. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently. , 1995, Biochemistry.
[14] T. Barth,et al. Semisynthetic insulin analogues modified in positions B24, B25 and B29. , 1994, Biological chemistry Hoppe-Seyler.
[15] T. Schwartz,et al. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker. , 2009, International journal of peptide and protein research.
[16] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[17] S. Shoelson,et al. Receptor binding redefined by a structural switch in a mutant human insulin , 1994, Nature.
[18] E J Dodson,et al. X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. , 1991, Journal of molecular biology.
[19] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[20] V. Kašička,et al. Correlation of capillary zone electrophoresis with continuous free‐flow zone electrophoresis: Application to the analysis and purification of synthetic growth hormone releasing peptide , 1990, Electrophoresis.
[21] R. Tsien. Fluorescent probes of cell signaling. , 1989, Annual review of neuroscience.
[22] H S Tager,et al. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. , 1986, The Journal of biological chemistry.
[23] I. Klimeš,et al. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination. , 1985, Endocrinologia experimentalis.
[24] R. Hubbard,et al. Insulin's structural behavior and its relation to activity , 1983, Biopolymers.
[25] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[26] C. Garratt,et al. The interaction of B29‐fluoresceinthiocarbamyl‐insulin with adipocyte membranes , 1980, FEBS letters.
[27] K. Inouye,et al. Enzyme-assisted semisynthesis of human insulin , 1979 .
[28] D. Lancet,et al. Spectroscopic and immunochemical studies with nitrobenzoxadiazolealanine, a fluorescent dinitrophenyl analogue. , 1977, Biochemistry.
[29] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[30] T. Blundell,et al. Receptor-binding region of insulin , 1976, Nature.
[31] Kenner Ra,et al. A new fluorescent probe for protein and nucleoprotein conformation. Binding of 7-(p-methoxybenzylamino)-4-nitrobenzoxadiazole to bovine trypsinogen and bacterial ribosomes. , 1971 .
[32] E. Kaiser,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.
[33] E. Arquilla,et al. Preparation and properties of fluoresceinthiocarbamyl insulins. , 1967, Biochemistry.
[34] G. Mortimore,et al. Preparation and properties of fluorescent insulin derivatives. , 1962, Biochimica et biophysica acta.